Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDarbà, Josep-
dc.description.abstractBackground : Spinal muscular atrophy (SMA) is a rare disorder, estimated to affect 1 per 10,000 live births. Patients affected with SMA often require intensive, chronic healthcare, which represents great social and economic costs. / Objective : This study aimed to evaluate the direct medical costs of SMA, from the National Health System perspective in Catalonia, and provide regional data for the development of optimal disease management protocols and resource allocation decisions at the regional level (...)-
dc.format.extent7 p.-
dc.publisherSpringer Nature-
dc.relation.isformatofVersió postprint del document publicat a:
dc.relation.ispartofClinical Drug Investigation, 2020, vol. 40, num. 4, p. 335-341-
dc.rights(c) Springer Nature, 2020-
dc.sourceArticles publicats en revistes (Economia)-
dc.subject.classificationAtròfia muscular-
dc.subject.classificationGestió hospitalària-
dc.subject.classificationPolítica sanitària-
dc.subject.classificationAnàlisi cost-benefici-
dc.subject.otherMuscular atrophy-
dc.subject.otherHospital administration-
dc.subject.otherMedical policy-
dc.subject.otherCost effectiveness-
dc.titleDirect Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis-
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
699617.pdf294.06 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.